SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028478
Filing Date
2023-08-14
Accepted
2023-08-14 16:16:03
Documents
70
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1144645
2 ex10-7.htm EX-10.7 85510
3 ex10-8.htm EX-10.8 58794
4 ex31.htm EX-31 22925
5 ex32.htm EX-32 5262
  Complete submission text file 0001493152-23-028478.txt   6501411

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE age-20230630.xsd EX-101.SCH 44275
7 XBRL CALCULATION FILE age-20230630_cal.xml EX-101.CAL 55479
8 XBRL DEFINITION FILE age-20230630_def.xml EX-101.DEF 199112
9 XBRL LABEL FILE age-20230630_lab.xml EX-101.LAB 338850
10 XBRL PRESENTATION FILE age-20230630_pre.xml EX-101.PRE 289806
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1100145
Mailing Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501
Business Address 1101 MARINA VILLAGE PARKWAY SUITE 201 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 231170418
SIC: 2834 Pharmaceutical Preparations